Sabine Kasimir-Bauer

Summary

Affiliation: Heinrich Heine University
Country: Germany

Publications

  1. ncbi DTCs in breast cancer: clinical research and practice
    W Janni
    Frauenklinik der Heinrich Heine Universität, Moorenstraße 5, Dusseldorf, Germany
    Recent Results Cancer Res 195:173-8. 2012
  2. ncbi Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns
    Dunja M Baston-Büst
    University Düsseldorf, Medical Faculty, Department of OB GYN and REI, Moorenstr, 5, 40225 Dusseldorf, Germany
    Reprod Biol Endocrinol 8:133. 2010
  3. ncbi Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
    Volkmar Muller
    Department of Gynecology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20241 Hamburg, Germany
    Breast Cancer Res 13:R71. 2011
  4. ncbi Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
    Carina Roth
    Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Breast Cancer Res 12:R90. 2010
  5. ncbi Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
    Carina Roth
    Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Germany
    BMC Cancer 11:4. 2011
  6. ncbi Treatment of pregnancy-associated breast cancer
    W Janni
    Frauenklinik der Heinrich Heine Universität, Dusseldorf, Germany
    Expert Opin Pharmacother 10:2259-67. 2009
  7. ncbi Adjuvant aromatase inhibitor therapy: outcomes and safety
    Wolfgang Janni
    Klinikdirektor der Frauenklinik, Klinikum der Heinrich Heine Universität, Moorenstr 5, 40225 Dusseldorf, Germany
    Cancer Treat Rev 36:249-61. 2010
  8. ncbi Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis
    Wolfgang Janni
    Frauenklinik der Heinrich Heine Universität, Dusseldorf, Germany
    Clin Cancer Res 17:2967-76. 2011
  9. ncbi The risk of urinary incontinence after partial urethral resection in patients with anterior vulvar cancer
    Monika Hampl
    Department of Obstetrics and Gynecology, University of Duesseldorf, Medical Faculty, Moorenstr 5, 40225 Duesseldorf, Germany
    Eur J Obstet Gynecol Reprod Biol 154:108-12. 2011

Collaborators

Detail Information

Publications9

  1. ncbi DTCs in breast cancer: clinical research and practice
    W Janni
    Frauenklinik der Heinrich Heine Universität, Moorenstraße 5, Dusseldorf, Germany
    Recent Results Cancer Res 195:173-8. 2012
    ..However, until clinical consequences of MRD detection in solid tumors and particularly in breast cancer have been validated, the detection of isolated tumor cells in bone marrow should be performed mainly in clinical trials...
  2. ncbi Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns
    Dunja M Baston-Büst
    University Düsseldorf, Medical Faculty, Department of OB GYN and REI, Moorenstr, 5, 40225 Dusseldorf, Germany
    Reprod Biol Endocrinol 8:133. 2010
    ....
  3. ncbi Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
    Volkmar Muller
    Department of Gynecology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20241 Hamburg, Germany
    Breast Cancer Res 13:R71. 2011
    ..The aim of the study was to investigate whether serum concentrations of TIMP-1 and CAIX are associated with the detection of CTC in metastatic breast cancer...
  4. ncbi Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
    Carina Roth
    Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Breast Cancer Res 12:R90. 2010
    ..Here we evaluated, for the first time, the feasibility and clinical utility of circulating miRs as biomarkers for the detection and staging of breast cancer...
  5. ncbi Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
    Carina Roth
    Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Germany
    BMC Cancer 11:4. 2011
    ....
  6. ncbi Treatment of pregnancy-associated breast cancer
    W Janni
    Frauenklinik der Heinrich Heine Universität, Dusseldorf, Germany
    Expert Opin Pharmacother 10:2259-67. 2009
    ..With an incidence of 1/3,000 to 1/10,000 pregnancies, pregnancy-associated breast cancer is the most common solid tumor in pregnancy after cervical carcinoma...
  7. ncbi Adjuvant aromatase inhibitor therapy: outcomes and safety
    Wolfgang Janni
    Klinikdirektor der Frauenklinik, Klinikum der Heinrich Heine Universität, Moorenstr 5, 40225 Dusseldorf, Germany
    Cancer Treat Rev 36:249-61. 2010
    ..Results of ongoing safety analyses within some of the large AI trials should provide further insight into the long-term tolerability of AI therapy in the adjuvant setting...
  8. ncbi Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis
    Wolfgang Janni
    Frauenklinik der Heinrich Heine Universität, Dusseldorf, Germany
    Clin Cancer Res 17:2967-76. 2011
    ..In view of the lack of early indicators for secondary adjuvant treatment, we here evaluated whether the persistence of DTCs after adjuvant therapy increases the risk of subsequent relapse and death...
  9. ncbi The risk of urinary incontinence after partial urethral resection in patients with anterior vulvar cancer
    Monika Hampl
    Department of Obstetrics and Gynecology, University of Duesseldorf, Medical Faculty, Moorenstr 5, 40225 Duesseldorf, Germany
    Eur J Obstet Gynecol Reprod Biol 154:108-12. 2011
    ..A retrospective analysis was performed in order to evaluate the risk of urinary incontinence after tumor-resection, standard inguinal lymphadenectomy and additional partial urethral resection...